A new clinical study supports powerful anti-aging skin benefits of Eternalyoung®, a blend of four botanical ingredients from Monteloeder, S. L., a subsidiary of Suanfarma. Eternalyoung is the result of extensive research and contains several polyphenols that work synergistically to provide anti-aging benefits for the skin. Continue reading
Category Archives: Health
This Week in Health News: Top Stories You Need to See
NEW YORK, April 14, 2023 /Health/– Here are some of the top health news stories from this week:
New COVID-19 variant BA.2 spreads rapidly in Europe and the US
US Supreme Court to hear case on abortion rights
WHO reports more than 1 million deaths from COVID-19
New study finds that obesity can increase risk of dementia
Researchers develop new drug that could treat Alzheimer’s disease
Continue reading
Medaica Announces Free Telehealth Stethoscope for Rural and Underserved Patients
Medaica, a digital health company extending the capability of home diagnostics, today announced that the U.S. Food and Drug Administration (FDA)-cleared1 Medaica M1 Telehealth Stethoscope (M1) will be free of charge, starting with qualifying strategic partners supporting rural or underserved patients with chronic heart and/or lung conditions. Continue reading
Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care
Roche (SIX: RO, ROG; OTCQX: RHHBY) introduces its navify® Algorithm Suite, a single platform hosting a library of digital medical algorithms that generate patient-centric insights and can aid earlier diagnosis of cancer and other conditions per intended use, at the HIMSS Global Conference in Chicago, USA, from April 17- 21, 2023. Continue reading
Beurer Insect Bite Healer, BR10
As we look forward to spending more time outside, wearing fewer layers, and taking in more sun, we also begin to get closer to the part of the season we all hate: insect bites. Whether you have to deal with mosquitoes, bee stings, deer flies, wasps, or no-see-ums, the sting can be equally painful and uncomfortable. Continue reading
Vuzix Smart Glasses Support New Partnership Designed to Solve Global Health Workforce Shortages
Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that its smart glasses have been selected to support a new partnership between med-tech specialist Global Health Education Group (“GHEG”) and the University of Leeds, one of the largest higher education institutions in the UK. GHEG has developed an online learning tool designed to significantly increase the accessibility, scale and quality of clinical training opportunities available to healthcare students. Continue reading
New Co-Authored Study Opens New Doors to Quantum-Powered Machine Learning and Medical Diagnostics
QC Ware, a leading quantum software and services company, announced today that a joint research project with one of the world’s leading biotechnology companies uncovered new discoveries in medical imaging analysis and diagnostics, leveraging quantum computing to better detect the presence and type of diabetic retinopathy. Continue reading
Pfizer Invests $43 Billion to Battle Cancer
Proposed combination enhances Pfizer’s position as a leading company in Oncology
Seagen’s medicines, late-stage development programs and pioneering expertise in Antibody-Drug Conjugates (ADCs) strongly complement Pfizer’s Oncology portfolio
Seagen expected to contribute more than $10 billion in risk-adjusted revenues in 2030
Pfizer and Seagen to hold analyst and investor call at 8 a.m. EDT today
NEW YORK & BOTHELL, Wash.–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise value of $43 billion. The Boards of Directors of both companies have unanimously approved the transaction. Continue reading
New Research in JNCCN Highlights the Negative Impact of Continued Exclusion of Racial Groups from Research on Cancer Genomics
New research in the March 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights how the lack of genomic research for people with African ancestry, particularly those from the Sub-Saharan region, is hampering efforts to reduce disparities for people with cancer. In a first-of-its-kind study, the researchers evaluated molecular genetic results for 113 Black South African men diagnosed with advanced prostate cancer to find evidence for increased and potentially unique genetic testing recommendations. Continue reading
icometrix & Queen Mary University of London receive prestigious AI Award from the National Institute for Health and Care Research (NIHR) to investigate the impact of AI applied to MRI in the care of people with multiple sclerosis (MS)
icometrix is proud to announce that, together with Queen Mary University of London (QMUL), it has been awarded the prestigious AI Award in Health and Care. This collaborative program will investigate the impact of AI on the assessment of MRI and decision making in the context of multi-disciplinary team meetings for people with MS. It is hoped that this research will lead to better care for people with MS (pwMS). Continue reading